Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Multiple Endocrine Neoplasia Type 1 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 46 Paclitaxel 42 Carboplatin 34 Bevacizumab 18 Specimen Handling 17 Letrozole 16 lenvatinib 13 Magnetic Resonance Spectroscopy 12 dostarlimab 11 Cisplatin 11 Biopsy 11 olaparib 10 Taxes 10 Fulvestrant 9 Doxorubicin 9 abemaciclib 8 Megestrol Acetate 8 Docetaxel 8 durvalumab 7 atezolizumab 7 Nivolumab 7 Gemcitabine 7 Blood Specimen Collection 7 palbociclib 6 Oxaliplatin 6 Observation 6 Fluorouracil 6 niraparib 5 Tirzepatide 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Levonorgestrel × 1 year × Clear all

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡